Biolegend, 100706, FITC anti-mouse CD8a Antibody, 500μg

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.
500μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Rat
Immunogen: Mouse thymus or spleen
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration: 0.5 mg/ml
Storage & Handling: The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)
Application Notes: Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).
Application References(PubMed link indicates BioLegend citation): Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP) Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete) Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP) Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block) Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC) Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC) Shih FF, et al. 2006. J. Immunol. 176:3438. (FC) Kamimura D, et al. 2006. J. Immunol. 177:306. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete) Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed Lee CH, et al. 2009. Clin. Cancer Res. PubMed Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed Kenna TJ, et al. 2008. Blood 111:2091. PubMed Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed Medyouf H, et al. 2010. Blood 115:1175. PubMed Riedl P, et al. 2009. J. Immunol. 183:370. PubMed Apte SH, et al. 2010. J. Immunol. 185:998. PubMed Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed Cui L, et al. 2015. J Control Release. 206:220. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations: Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed Liu J, et al. 2019. Immunity. 50:600. PubMed Strickley JD, et al. 2019. Nature. 575:519. PubMed Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed Lee KM, et al. 2022. Cancer Immunol Res. 10:829. PubMed Puth S, et al. 2022. Biomaterials. 286:121542. PubMed Alghamri MS, et al. 2022. ACS Nano. 16:8729. PubMed Edwards KJ, et al. 2022. Cancer Immunol Res. 10:1084. PubMed Akhtar MN, et al. 2022. MBio. 13:e0330921. PubMed Konjar S, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202144119. PubMed Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed Ma X, et al. 2023. Nat Commun. 14:1606. PubMed Zhuang WR, et al. 2023. Nat Commun. 14:1675. PubMed Li D, et al. 2023. Ann Med. 55:2189295. PubMed Bhatia V, et al. 2023. Nat Commun. 14:2041. PubMed Chen F, et al. 2023. Acta Biomater. 164:387. PubMed Li Y, et al. 2023. Front Cell Infect Microbiol. 13:1117230. PubMed Wang K, et al. 2023. Nat Commun. 14:2950. PubMed Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed Park HJ, et al. 2023. NPJ Vaccines. 8:84. PubMed Seo YB, et al. 2023. Int J Mol Sci. 24:. PubMed Pagano G, et al. 2023. Haematologica. . PubMed Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed Milanovic M, et al. 2021. Cancer Res. 81:426. PubMed Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed Chakraborty P, et al. 2022. Cancer Res. 82:1969. PubMed Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed Corral D, et al. 2022. Cell Rep. 39:110715. PubMed Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed Chowdhury S, et al. 2022. Cancer Res. 82:2640. PubMed Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed Liu W, et al. 2022. Biomedicines. 10: . PubMed Deng P, et al. 2022. J Clin Invest. 132: . PubMed Sun Y, et al. 2023. Bioact Mater. 22:47. PubMed Li J, et al. 2022. Front Immunol. 13:1043484. PubMed Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed Weng S, et al. 2022. Front Immunol. 13:1025931. PubMed Ding L, et al. 2023. J Clin Invest. 133: . PubMed Choi H, et al. 2023. J Nanobiotechnology. 21:5. PubMed Wang L, et al. 2022. Nutrients. 15: . PubMed Zhang B, et al. 2023. Signal Transduct Target Ther. 8:28. PubMed Elliot TAE, et al. 2022. Discov Immunol. 1:kyac009. PubMed Kemna J, et al. 2023. Nat Immunol. 24:414. PubMed Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed Milanovic M, et al. 2021. J Immunol. 206:1228. PubMed Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed Friedman D, et al. 2022. J Immunol. 208:1845. PubMed Wu MJ, et al. 2022. Cancer Discov. 12:812. PubMed Yao RQ, et al. 2022. Theranostics. 12:4606. PubMed Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed Lin W, et al. 2020. Theranostics. 10:4871. PubMed Yang H, et al. 2019. Mol Metab. 23:24. PubMed Taddeo A, et al. 2022. NPJ Vaccines. 7:82. PubMed Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed Ren S, et al. 2019. Oncol Rep. 41:1509. PubMed Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed Seo YB, et al. 2021. Vaccines (Basel). 9: . PubMed Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed Hao B, et al. 2015. J Exp Med. 212:809. PubMed Apte S, et al. 2010. J Immunol. 185:998. PubMed Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed Greenberg J, et al. 2022. JCI Insight. Online ahead of print. PubMed Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed Yang X, et al. 2020. Blood Sci. 2:89. PubMed Wang Q, et al. 2020. Wound Repair Regen. 28:105. PubMed Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed Morales D, et al. 2015. J Virol. 89:337. PubMed Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed Lutes LK, et al. 2021. eLife. 10:00. PubMed Okamoto T, et al. 2020. Cancer Res. 3580:80. PubMed Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed Brooks JF, et al. 2020. Cytotherapy. 22:436. PubMed Antonia O Cuff et al. 2017. Wellcome open research. 2:39 . PubMed Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed Treger RS, et al. 2020. Immunity. 50(2):334-347.e9.. PubMed Yoon Y, et al. 2021. Cancers (Basel). 13: . PubMed Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed Wang Y, et al. 2022. Acta Pharm Sin B. 12:262. PubMed Wu K, et al. 2021. Aging (Albany NY). 13:. PubMed Mukherjee D, et al. 2022. Nat Commun. 13:3747. PubMed Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed Tu X, et al. 2022. Nat Commun. 13:6977. PubMed Magod P, et al. 2021. Cell Reports. 36(5):109480. PubMed Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed Artinger K, et al. 2015. PLoS One. 10: 0135087. PubMed Shade K, et al. 2015. J Exp Med. 212:457. PubMed DeBerge M, et al. 2013. PLoS One. 8:79340. PubMed Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed Suah AN, et al. 2021. J Clin Invest. 131:. PubMed Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed Nicolay N, et al. 2016. Sci Rep. 6: 26645. PubMed Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed Zhang F, et al. 2019. Immunity. 50:738. PubMed Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed MacDonald A, et al. 2021. Front Immunol. 12:755995. PubMed Zebley CC, et al. 2021. Cell Rep. 37:109796. PubMed Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed Wu J, et al. 2020. Immunity. 53:115. PubMed Köchl R, et al. 2020. Elife. 9:00. PubMed Len-Letelier RA, et al. 2020. Frontiers in Immunology. 11:583382. PubMed Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed Xiao P, et al. 2019. J Exp Med. 216:337. PubMed Topper MJ et al. 2017. Cell. 171(6):1284-1300 . PubMed Li Y, et al. 2019. Sci Rep. 9:6932. PubMed Wu L, et al. 2022. Theranostics. 12:842. PubMed Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed Drees J, et al. 2015. Anticancer Res. 35:843. PubMed Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed Webster P, et al. 2018. Nat Commun. 9:2649. PubMed Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed Pishesha N, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed Yang J, et al. 2020. Nature. 586:572. PubMed Knocke S, et al. 2016. Cell Rep. 17:2234-2246. PubMed Ito C, et al. 2015. PLoS One. 10: e0140808. PubMed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Wan X, et al. 2018. Nature. 560:107. PubMed Qi S et al. 2016. eLife. 5 pii: e14756. PubMed Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed Kim JH, et al. 2019. Mol Med. 25:33. PubMed Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed Vaena S, et al. 2021. Cell Reports. 35(5):109076. PubMed Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed Du J, et al. 2018. AMB Express. 8:158. PubMed Holman P, et al. 2005. J Immunol. 174:3986. PubMed Huang Z, et al. 2021. Nat Commun. 12:145. PubMed Grioni M, et al. 2021. Blood Adv. 5:2817. PubMed Matundan HH, et al. 2021. J Virol. 95:e0103621. PubMed Bosnjak B, et al. 2021. Front Immunol. 12:772240. PubMed Sun C, et al. 2022. J Adv Res. 35:71. PubMed Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed Zheng D, et al. 2022. Acta Pharm Sin B. 12:2740. PubMed Liu B, et al. 2022. Mol Med Rep. 26:. PubMed Nikolos F, et al. 2022. Nat Commun. 13:1487. PubMed Yan J, et al. 2020. Cell Rep. 107820:31. PubMed Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed Shen JZ, et al. 2020. Cell. 184(2):352-369.e23. PubMed Li X, et al. 2020. Nat Commun. 4.877777778. PubMed Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed Wang R, et al. 2022. Front Immunol. 13:947756. PubMed Jin C, et al. 2022. Oncoimmunology. 11:2099642. PubMed Frost JN, et al. 2021. Med (N Y). 2:164. PubMed Daneshmandi S, et al. 2021. Elife. 10:. PubMed Huang L, et al. 2021. Breast Cancer Res Treat. Online ahead of print. PubMed Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed Blagih J, et al. 2020. Cell Rep. 30:481. PubMed Fu S, et al. 2020. Nat Commun. 0.7625. PubMed Tao Z, et al. 2019. Clin Cancer Res. 25:1113. PubMed Zhang NN, et al. 2020. Cell. 182(5):1271-1283. PubMed Bartolacci C, et al. 2018. Cancer Immunol Res. 1.281944444. PubMed Riedl P, et al. 2009. J Immunol. 183:370. PubMed Zhan L, et al. 2022. Cancer Lett. 529:37. PubMed Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Kvell K, et al. 2014. Immunobiology. 219:644. PubMed Dulken BW, et al. 2019. Nature. 571:205. PubMed Hu Z, et al. 2020. PLoS One. 15:e0228339. PubMed Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed Feng D, et al. 2022. Nat Commun. 13:5554. PubMed He C, et al. 2022. Nat Commun. 13:5459. PubMed Li M, et al. 2021. Cancers (Basel). 13:. PubMed Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed Fang F, et al. 2021. Cell Rep. 37:109981. PubMed Shen L, et al. 2015. Cancer Immunol Res. 3:136. PubMed Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed Miura N, et al. 2017. Mol Ther. 10.1016/j.ymthe.2017.01.020. PubMed Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed Xia Y, et al. 2018. Cell. 175:1059. PubMed Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed Panigrahy D, et al. 2019. J Clin Invest. 130:2964. PubMed Wu P, et al. 2020. Cancer Immunol Res. 8:1470. PubMed Soria-Castro R, et al. 2020. Sci Rep. 10:17802. PubMed Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed Kos S, et al. 2019. PLoS One. 14:e0217762. PubMed Li Q, et al. 2022. Front Oncol. 12:841977. PubMed Kung YJ, et al. 2022. J Biomed Sci. 29:57. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Ren Y, et al. 2021. Nat Commun. 12:5405. PubMed Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed Sivapatham S, et al. 2019. Front Immunol. 1.865277778. PubMed Royzman D, et al. 2019. Front Immunol. 10:633. PubMed Tsyklauri O, et al. 2021. EMBO Rep. 22:e50785. PubMed Petriv N, et al. 2021. Oncoimmunology. 10:1874159. PubMed Kim S, et al. 2022. Cancers (Basel). 14:. PubMed Zhang Z, et al. 2020. Nature. 579:415. PubMed Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed Chakraborty P, et al. 2020. Cell Reports. 28(7):1879-1893.e7.. PubMed Fleskens V, et al. 2019. Cell Rep. 26:3600. PubMed Li K, et al. 2020. Nat Commun. 0.795138889. PubMed Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed Li X, et al. 2022. Oncoimmunology. 11:2118210. PubMed Li H, et al. 2022. iScience. 25:104481. PubMed Wang X, et al. 2022. Elife. 11:. PubMed D'Cruz L, et al. 2014. J Immunol. 192:2227. PubMed Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed Hebbandi Nanjundappa R, et al. 2017. Cell. 171:655. PubMed Tanegashima K et al. 2017. EBioMedicine. 24:247-256 . PubMed Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed Kim YS, et al. 2018. Front Immunol. 9:1093. PubMed Wen X, et al. 2021. World J Gastroenterol. 27:2834. PubMed Wang K, et al. 2021. Nat Commun. 12:4558. PubMed Xie L, et al. 2020. Infect Immun. :88. PubMed Hayashi K, et al. 2020. Nat Commun. 4.832638889. PubMed Schlecker E, et al. 2012. J Immunol. 189:5602. PubMed Zhi Y, et al. 2020. Int J Mol Med. 45:1327. PubMed Bing Wu et al. 2018. Immunity. 49(5):886-898 . PubMed Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed Lee S, et al. 2021. Autophagy. 18:1062. PubMed Song X, et al. 2022. Transl Oncol. 15:101306. PubMed Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed Gu Z, et al. 2021. Nat Genet. 53:672. PubMed Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
RRID: AB_312744 (BioLegend Cat. No. 100705) AB_312745 (BioLegend Cat. No. 100706)
Structure: Ig superfamily, CD8α chain, 34 kD
Distribution: Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells
Function: Co-receptor for TCR
Ligand/Receptor: MHC class I molecule
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Zamoyska R. 1994. Immunity 1:243. 3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.
Gene ID: 12525
UniProt: View information about CD8alpha on UniProt.org
Clone: 53-6.7
Regulatory Status: RUO
Other Names: T8, Lyt2, Ly-2
Isotype: Rat IgG2a, κ